ABSTRACT NUMBER: ESOC2026LB182 EVALUATION OF ANTITHROMBOTIC THERAPY FOLLOWING FIRST PRESENTATION OF STROKE. A POPULATION-LEVEL OBSERVATIONAL COHORT STUDY IN WALES.

Daniel Harris, Laura Herbert, Jonathan Hewitt · 2026

Read ABSTRACT NUMBER: ESOC2026LB182 EVALUATION OF ANTITHROMBOTIC THERAPY FOLLOWING FIRST PRESENTATION OF STROKE. A POPULATION-LEVEL OBSERVATIONAL COHORT STUDY IN WALES. by Daniel Harris, Laura Herbert, Jonathan Hewitt (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13144788.txt.

Description

Daniel Harris, Laura Herbert, and Jonathan Hewitt present a 2026 study of drug care after a first stroke in Wales. Drugs that slow clotting help prevent a second stroke, but use after a first event had not been checked at this scale. The team drew on health records for the whole country.

The study followed 52,400 people with a first stroke between 2010 and 2023 for at least one year. After a blocked vessel stroke, about two thirds took a platelet drug, the class most guidelines favor. Care for patients with an uneven heart rhythm was also reviewed. The authors found that about two thirds of survivors seemed to be on fitting drug care, while use varied more after other stroke types.

Catalog record

CREATORDaniel Harris, Laura Herbert, Jonathan Hewitt
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13144788

Browse the full library · About the Tower of Babel